Moreover, the H158Y mutant of SIRT5 failed to inhibit the formation of the PPA2-NEDD4 complex and subsequent ubiquitin-mediated proteasomal degradation of HIF-1α, suggesting that the catalytic activity of SIRT5 is required for its oncogenic function in CRC. The gene discussed is SIRT5; the disease is colorectal carcinoma.